Tag: BioNTech

BioNTech doesn’t need much of an introduction—its mRNA COVID-19 vaccine put the company on the global map. But BioNTech is much more than a vaccine company. With a strong focus on oncology, BioNTech has numerous late-stage assets in development that could change the future of cancer treatment. Its former COO, Sean Marett, was on the show recently, so please feel free to check out the episode.